cognitive behaviolral familly therapy for chronic pain

Effect of family participation cognitive behavioral therapy for chronic pain using video conference system: pilot randomized controlled trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030200356

Enrollment

Registered

2021-02-09

Start date

2021-02-09

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

somatic symptom disorder with predominant pain chronic pain

Interventions

Remote family cognitive behavioral therapy (CBFT) using a video conferencing system will be conducted for 10 consecutive weeks in addition to regular medical care. CFBT follows the program and partici

D015928

Cognitive Behavior Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for "physical symptoms (pain is the main symptom)" in DSM-5 2) 18 years of age or older at the time of obtaining consent. 3)One or more reports of interference with daily life due to patient's pain from a family member living together. 4) To practice cognitive-behavioral therapy once a week (10 times in total) with their family (living together in principle). 5) Continuing regular treatment for chronic pain and not be planed to started new drug therapy. 6) Have internet environment at home and can perform online treatment.

Exclusion criteria

Exclusion criteria: Those who meet any of the following conditions are not eligible. 1) Have neurocognitive disorder group, psychotic disorder, bipolar disorder, substance-related disorder and other serious mental disorders in DSM-5. 2) cancer pain. 3) Mental developmental delay, neurocognitive impairment (dementia) , autism spectrum disorder. 4) Have serious progressive physical illness. 5) judged to be inappropriate for conducting this examination safely by the investigator or the psychiatrist. 6) Have pain proceedings or compensation issues

Design outcomes

Primary

Measure	Time frame
BPI total score from session1 to session10	—

Secondary

Measure	Time frame
Change of score from session 1 to session16 and to 3 month follow-up. BPI pain severity and pain interference EuroQol 5 Dimension (EQ-5D-5L) Pain Catastrophizing Scale (PCS) Pain Disability Assessment Scale (PDAS) Beck Depression Inventory 2 (BDI 2) Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) WHO QOL 26 Client Satisfaction Questionnaire (CSQ-8) Injustice Experience Questionnaire chronic (IEQ-chr)	—

Measure

Time frame

Change of score from session 1 to session16 and to 3 month follow-up. BPI pain severity and pain interference EuroQol 5 Dimension (EQ-5D-5L) Pain Catastrophizing Scale (PCS) Pain Disability Assessment Scale (PDAS) Beck Depression Inventory 2 (BDI 2) Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) WHO QOL 26 Client Satisfaction Questionnaire (CSQ-8) Injustice Experience Questionnaire chronic (IEQ-chr)

—

Contacts

Public ContactKayoko Taguchi

Chiba University

k.taguchi@chiba-u.jp+81-43-226-2027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026